Figure 4 Lack of protective effects of dietary supplementation with non-aggregating mutant L. crispatus MU5 on DSS colitis. DSS colitis was induced as.

Slides:



Advertisements
Similar presentations
Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice  Susana Sánchez-Fidalgo, Ana Cárdeno, Marina.
Advertisements

Fig. 1. Treatment with S. japonicum cercariae resulted in reduced susceptibility to DSS-induced colitis in mice. Mice were infected with 20±2 S. japonicum.
Figure 2 Effect of protease inhibitors added incubated 1 h at room temperature on biomarker detection in whole saliva. Results are expressed as mean channel.
Volume 124, Issue 5, Pages (May 2003)
Figure 1 Protective effects of acellular pertussis vaccines (A–F) in the respiratory infection model. Mice were challenged by exposure to an aerosol of.
Christian F. Krieglstein, Christoph Anthoni, Wolfgang H
Figure 5 Transferrin saturation, NTBI and bacterial growth in the serum of three stem cell transplantation patients, of whom one (A) did not receive apotransferrin.
Volume 131, Issue 4, Pages (October 2006)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 119, Issue 1, Pages (July 2000)
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Volume 131, Issue 3, Pages (September 2006)
Volume 42, Issue 4, Pages (April 2015)
Volume 135, Issue 4, Pages (October 2008)
Volume 125, Issue 1, Pages (July 2003)
Histological features of murine DSS-induced colitis.
Volume 132, Issue 4, Pages (April 2007)
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Volume 119, Issue 1, Pages (July 2000)
Volume 131, Issue 4, Pages (October 2006)
Volume 20, Issue 7, Pages (August 2017)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 10, Issue 1, Pages (January 2015)
Volume 124, Issue 5, Pages (May 2003)
Volume 17, Issue 6, Pages (December 2002)
Volume 25, Issue 4, Pages (April 2014)
Volume 128, Issue 4, Pages (April 2005)
Volume 131, Issue 3, Pages (September 2006)
Volume 144, Issue 5, Pages e6 (May 2013)
Galectin-1 suppresses experimental colitis in mice
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 24, Issue 5, Pages (November 2013)
Volume 132, Issue 3, Pages (March 2007)
Volume 141, Issue 4, Pages (October 2011)
Volume 134, Issue 1, Pages (January 2008)
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 14, Issue 1, Pages (July 2013)
Volume 139, Issue 6, Pages (December 2010)
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice  Tohru Funakoshi, Kenichiro Yamashita, Nobuki.
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 125, Issue 6, Pages (December 2003)
Volume 36, Issue 2, Pages (February 2012)
Volume 125, Issue 6, Pages (December 2003)
Volume 29, Issue 6, Pages (December 2008)
Role of meprin A in renal tubular epithelial cell injury
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Therapeutic effects of TIP60 allosteric modification in DSS-induced colitis. Therapeutic effects of TIP60 allosteric modification in DSS-induced colitis.
Effects of IL-1α on the composition of infiltrating proinflammatory cells in inflamed colons during DSS-induced colitis. Effects of IL-1α on the composition.
Silvina Gazzaniga, Alicia Bravo, Silvana R
Volume 19, Issue 13, Pages (June 2017)
Volume 119, Issue 4, Pages (October 2000)
Volume 135, Issue 5, Pages e5 (November 2008)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Volume 132, Issue 3, Pages (March 2007)
Leptin: A pivotal mediator of intestinal inflammation in mice
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Volume 25, Issue 7, Pages (July 2017)
Volume 132, Issue 2, Pages (February 2007)
Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis  Jun Lu, Arthur Wang, Sara Ansari,
Volume 30, Issue 6, Pages (June 2009)
Volume 131, Issue 2, Pages (August 2006)
Volume 17, Issue 5, Pages (October 2016)
Volume 13, Issue 6, Pages (June 2013)
Volume 125, Issue 3, Pages (September 2003)
Volume 136, Issue 7, Pages (June 2009)
B. fragilis utilizes TLR2 signaling for its protective role against the development of colitis-associated cancer in mice. B. fragilis utilizes TLR2 signaling.
a b c Supplementary Figure 1
Presentation transcript:

Figure 4 Lack of protective effects of dietary supplementation with non-aggregating mutant L. crispatus MU5 on DSS colitis. DSS colitis was induced as described in Section 2, 24 h after the induction of colitis animals were randomly divided to receive once a day (for 3 days) either 10<sup>8</sup>L. crispatus M247, 10<sup>8</sup>L. crispatus MU5 in MRS medium or 10<sup>8</sup>L. crispatus MU5 in a 30% sucrose solution. Severity of colitis was determined by body weight change (panel a), results are shown as percent change over the initial body weight, and MPO activity in full thickness sections of proximal colon, expressed as U/mg wet tissue (panel b). As shown in panels a and b administration of non-aggregating mutant L. crispatus MU5 resulted in the complete loss of the protective effects, whereas administration of the adhesion deficient strain in a 30% sucrose solution restore the protective effect on colitis. Values are means ± SEM. <sup>*</sup>P < 0.05 vs control; <sup>**</sup>P < 0.01 vs control, <sup>+</sup>P < 0.05 vs DSS alone; <sup>++</sup>P < 0.01 vs DSS alone. From: Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice FEMS Immunol Med Microbiol. 2005;43(2):197-204. doi:10.1016/j.femsim.2004.08.011 FEMS Immunol Med Microbiol | © 2004 Federation of European Microbiological Societies.

Figure 3 Effect of conditioning the colonic lumen with L Figure 3 Effect of conditioning the colonic lumen with L. crispatus M247 before the onset of DSS colitis. L. crispatus M247 (10<sup>8</sup> bacteria) were administered daily for 5 consecutive days and then stopped at the time of DSS administration. Colitis induced body weight loss and colonic mucosal MPO levels were determined after 5 days. Panel a shows the absence of any protective effect of pre-conditioning of colonic lumen by L. crispatus M247 on DSS-induced weight loss. Panel b shows that pre-conditioning of colonic lumen with L. crispatus M247 reduced by 30% mucosal MPO activity (P < 0.05) as compared to DSS treated mice. Values are means ± SEM. <sup>*</sup>P < 0.05 vs control; <sup>**</sup>P < 0.01 vs control. From: Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice FEMS Immunol Med Microbiol. 2005;43(2):197-204. doi:10.1016/j.femsim.2004.08.011 FEMS Immunol Med Microbiol | © 2004 Federation of European Microbiological Societies.

Figure 2 Protective effects of dietary supplementation with L Figure 2 Protective effects of dietary supplementation with L. crispatus M247 during DSS colitis. To induce colitis mice received 5% DSS in their drinking water for 5 days. After 24 h of DSS administration animals were randomly divided to receive daily (for 3 days) either live L. crispatus M247 (10<sup>4</sup>, 10<sup>6</sup> or 10<sup>8</sup> bacteria), 10<sup>8</sup>B. clausii spores or 10<sup>8</sup> heat killed L. crispatus M247. Severity of colitis was monitored by measure of the body weight and results are shown as percent change over initial body weight (panel a). At the end of the experiment animals were killed, and full-thickness samples of the proximal colon were collected to determine MPO activity, expressed as U/mg wet tissue (panel b) or fixed in 10% PFA, paraffin embedded and sections stained with H & E were analyzed by a pathologist in a blinded fashion. Original magnification was 40× (panel c). Panel c shows a representative colonic section from a control mouse (left), a mouse receiving DSS alone (middle) or treated with 10<sup>8</sup>L. crispatus M247 (right). Mucosal ulceration and inflammatory cell infiltrate are drastically reduced in L. crispatus M247 — treated mice (compare II and III). Results are expressed as means ± SEM. <sup>*</sup>P < 0.05 vs control; <sup>**</sup>P < 0.01 vs control, <sup>+</sup>P < 0.05 vs DSS alone; <sup>++</sup>P < 0.01 vs DSS alone. From: Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice FEMS Immunol Med Microbiol. 2005;43(2):197-204. doi:10.1016/j.femsim.2004.08.011 FEMS Immunol Med Microbiol | © 2004 Federation of European Microbiological Societies.

Figure 1 L. crispatus M247 adhering to colon mucosal surface by scanning electron microscopy. Full thickness colonic segments from normal mice were incubated 10 min with 10<sup>8</sup> CFU/ml L. crispatus M247, then thoroughly washed with PBS and fixed with 2.5% glutaraldheyde. Sections were examined by a scanning electron microscope XL30 ESEM (Philips). Panel a shows a representative image of M247 cell adhering to colon mucosal surface and to mucus fibers (7000×), panel b shows clusters of M247 cells adhering to the mucosal surface (5000×). From: Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice FEMS Immunol Med Microbiol. 2005;43(2):197-204. doi:10.1016/j.femsim.2004.08.011 FEMS Immunol Med Microbiol | © 2004 Federation of European Microbiological Societies.